Insider: DeLong Mark Jeffrey Chief Business & Strat Officer - Apellis Pharmaceuticals, Inc.
| Company Holdings |
| Direct | Indirect Ownership | Total | |
| Shares | 83,945 | 0 | 83,945 |
| Value | $1,877,849.65 | $0.00 | $1,877,849.65 |
Trans. Date |
Trans. Type |
Shares |
Ownership Type |
Issue Type |
Price |
Trans. Value |
Total Shares Owned |
|---|---|---|---|---|---|---|---|
| 02/11/2025 | DDS | 363 | Direct | COM | $28.54 | $10,359.58 | 83,945 |
| 01/29/2025 | DDS | 365 | Direct | COM | $29.52 | $10,776.11 | 84,308 |
| 01/22/2025 | DDS | 1,396 | Direct | COM | $30.43 | $42,474.00 | 84,673 |
| 01/17/2025 | DDS | 1,235 | Direct | COM | $29.96 | $36,998.38 | 57,561 |
| 01/13/2025 | DDS | 1,599 | Direct | COM | $28.70 | $45,894.66 | 58,796 |
| 03/18/2024 | DDS | 9,913 | Direct | COM | $56.90 | $564,049.70 | 54,693 |
| 02/12/2024 | DDS | 597 | Direct | COM | $67.77 | $40,456.84 | 64,606 |
| 01/29/2024 | DDS | 367 | Direct | COM | $64.14 | $23,538.72 | 65,203 |
| 01/22/2024 | DDS | 1,384 | Direct | COM | $65.00 | $89,954.46 | 65,570 |
| 01/16/2024 | DDS | 1,631 | Direct | COM | $66.81 | $108,964.83 | 66,954 |
| 10/23/2023 | DDS | 131 | Direct | COM | $46.04 | $6,030.74 | 51,622 |
| 08/17/2022 | DDS | 5,000 | Direct | COM | $69.50 | $347,500.00 | 29,250 |
| 08/11/2022 | DDS | 5,000 | Direct | COM | $67.00 | $335,000.00 | 29,250 |
| 08/08/2022 | DDS | 5,000 | Direct | COM | $64.50 | $322,500.00 | 29,250 |
| 08/04/2022 | DDS | 5,000 | Direct | COM | $59.50 | $297,500.00 | 34,250 |
| 08/04/2022 | DDS | 5,000 | Direct | COM | $62.00 | $310,000.00 | 29,250 |
| 07/27/2022 | DDS | 5,000 | Direct | COM | $57.00 | $285,000.00 | 29,250 |
| 07/19/2022 | DDS | 5,000 | Direct | COM | $56.42 | $282,100.00 | 29,250 |
| 06/16/2022 | DDS | 10,000 | Direct | COM | $41.79 | $417,850.00 | 29,250 |
| 04/20/2022 | DDS | 7,000 | Direct | COM | $52.53 | $367,710.00 | 28,481 |
| 07/21/2021 | DDS | 1,000 | Direct | COM | $65.00 | $65,000.00 | 9,490 |
| 07/15/2021 | DDS | 1,000 | Direct | COM | $62.30 | $62,300.00 | 9,490 |
| 06/15/2021 | DDS | 4,000 | Direct | COM | $64.96 | $259,830.00 | 9,490 |
| 05/18/2021 | DDS | 2,000 | Direct | COM | $55.00 | $110,000.00 | 9,490 |
| 1 You are at page 1 of 1 pages |
|
Transaction Type Key First letter: A = Acquired, D = Disposed Second letter: A = Grant, award or other acquisition pursuant to Rule 16b-3(d) C = Conversion of derivative security | D = Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | E = Expiration of short derivative position | F = Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3. | G = Gift | H = Expiration (or cancellation) of long derivative position with value received | I = Discretionary transaction in accordance with Rule 16b-3(f) | J = Other | L = Small acquisition under Rule 16a-6 | M = Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | O = Exercise of out-of-the-money derivative security | P = Open market or private purchase | S = Open market or private sale | U = Disposition pursuant to a tender of shares in a change of control transaction | W = Acquisition or disposition by will or the laws of descent and distribution | X = Exercise of in-the-money or at-the-money derivative security | Z = Deposit into or withdrawal from voting trust |
 |
Send to Excel |
© 2000 - 2025 Zacks Investment Research